SILEXION THERAPEUTICS CORP Operating Cash Flow
SILEXION THERAPEUTICS CORP (SLXN) reported Operating Cash Flow of -$2.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- SILEXION THERAPEUTICS CORP net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.92M.
- SILEXION THERAPEUTICS CORP net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.65M.
- SILEXION THERAPEUTICS CORP net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.02M.
- SILEXION THERAPEUTICS CORP net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$2.84M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.92M 10-Q · filed 2026-08-14 | -$6.57M 10-Q · filed 2026-08-14 | -$9.59M derived: sum of 3 quarters · filed 2026-08-14 | -$12.43M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$3.65M S-1/A · filed 2026-08-10 | -$6.66M derived: sum of 2 quarters · filed 2026-08-10 | -$9.51M derived: sum of 3 quarters · filed 2026-08-10 | -$12.01M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$3.02M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$5.86M derived: sum of 2 quarters · filed 2026-08-10 | -$8.37M derived: sum of 3 quarters · filed 2026-08-14 | -$10.82M S-1/A · filed 2026-08-10 |
| 2025-09-30 | -$2.84M 10-Q · filed 2025-11-12 | -$5.35M derived: sum of 2 quarters · filed 2026-08-14 | -$7.80M 10-Q · filed 2025-11-12 | -$10.73M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$2.51M 10-Q · filed 2026-08-14 | -$4.96M 10-Q · filed 2026-08-14 | -$7.89M derived: sum of 3 quarters · filed 2026-08-14 | -$10.54M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$2.45M S-1/A · filed 2026-08-10 | -$5.38M derived: sum of 2 quarters · filed 2026-08-10 | -$8.03M derived: sum of 3 quarters · filed 2026-08-10 | -$9.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2024-12-31 | -$2.93M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-10 | -$5.58M derived: sum of 2 quarters · filed 2026-08-10 | -$6.64M derived: sum of 3 quarters · filed 2026-08-10 | -$8.40M S-1/A · filed 2026-08-10 |
| 2024-09-30 | -$2.65M 10-Q · filed 2025-11-12 | -$3.72M derived: sum of 2 quarters · filed 2025-11-12 | -$5.47M 10-Q · filed 2025-11-12 | -$6.73M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.06M 10-Q · filed 2025-08-12 | -$2.82M 10-Q · filed 2025-08-12 | -$4.07M derived: sum of 3 quarters · filed 2025-08-20 | -$4.76M derived: sum of 4 quarters · filed 2025-08-20 |
| 2024-03-31 | -$1.75M 10-Q · filed 2025-05-13 | -$3.01M derived: sum of 2 quarters · filed 2025-08-20 | -$3.69M derived: sum of 3 quarters · filed 2025-08-20 | -$5.37M derived: sum of 4 quarters · filed 2025-08-20 |
| 2023-12-31 | -$1.26M derived: 8-K 12 month − 10-Q 9 month · filed 2025-08-20 | -$1.94M derived: sum of 2 quarters · filed 2025-08-20 | -$3.62M derived: sum of 3 quarters · filed 2025-08-20 | -$4.53M 8-K · filed 2025-08-20 |
| 2023-09-30 | -$685.00K 10-Q · filed 2024-11-14 | -$2.36M derived: sum of 2 quarters · filed 2024-11-14 | -$3.27M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$1.68M 10-Q · filed 2024-08-29 | -$2.59M 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |